Search    ENTER KEYWORD
MSDS Material Safety Data Sheet
CAS

44-20-8
67-97-0
59-02-9

File Name: msds-gsk_com---12746807.asp
SDS Number 127468              Approved/Revised 13-Apr-2007                                        Version 7
OS-CAL 500 + D TABLETS
Material



SAFETY DATA SHEET




1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE
COMPANY/UNDERTAKING
Material OS-CAL 500 + D TABLETS
OS-CAL 500 + D [200IU] CAPLETS * OS-CAL 500 MG + D TABLETS (US) *
Synonyms
MFC 50357B * CALCIUM CARBONATE AND VITAMIN D, FORMULATED
PRODUCT
GlaxoSmithKline, Corporate Environment, Health & Safety
Company Name
980 Great West Road
Brentford, Middlesex TW8 9GS UK
UK General Information: +44-20-8047-5000
Transport Emergency (EU) +44-1865-407333
Medical Emergency +1-612-221-3999, Ext 221
Information and Advice: US number, available 24 hours
Multi-language response

GlaxoSmithKline, Corporate Environment, Health & Safety
One Franklin Plaza, 200 N 16th Street
Philadelphia, PA 19102-1225 US
US General Information: +1-888-825-5249
Transport Emergency (non EU) +1-703-527-3887
US number, available 24 hours
Multi-language response

2. COMPOSITION / INFORMATION ON INGREDIENTS
Percentage
Ingredients CAS RN
OYSTER SHELL POWDER 81.4
Unassigned
CHOLECALCIFEROL 0.0005
67-97-0
D-ALPHA-TOCOPHEROL 0.0004
59-02-9
NON-HAZARDOUS INGREDIENTS 18.6
Unassigned

3. HAZARDS IDENTIFICATION
Expected to be non-combustible.
Fire and Explosion
Health Skin irritant. Severe eye irritant.
Health effects information is based on hazards of components.
Environment No information is available about the potential of this product to produce
adverse environmental effects.

4. FIRST-AID MEASURES


Page 1 / 4
SDS Number 127468 Approved/Revised 13-Apr-2007 Version 7
OS-CAL 500 + D TABLETS
Material


Ingestion Never attempt to induce vomiting. Do not attempt to give any solid or liquid
by mouth if the exposed subject is unconscious or semi-conscious. Wash
out the mouth with water. If the exposed subject is fully conscious, give
plenty of water to drink. Obtain medical attention.
Inhalation Physical form suggests that risk of inhalation exposure is negligible.
Skin Contact Using appropriate personal protective equipment, remove contaminated
clothing and flush exposed area with large amounts of water. Obtain
medical attention if skin reaction occurs, which may be immediate or
delayed.
Eye Contact Wash immediately with clean and gently flowing water. Continue for at least
15 minutes. Obtain medical attention.
NOTES TO HEALTH PROFESSIONALS
Medical Treatment Because of the potential for acute or delayed eye damage, consider referral
to an ophthalmologist.
Medical Conditions None for occupational exposure.
Caused or Aggravated
by Exposure
Antidotes No specific antidotes are recommended.

5. FIRE-FIGHTING MEASURES
Fire and Explosion Not expected for the product, although the packaging is combustible.
Hazards
Extinguishing Media Water or foam extinguishers are recommended.
Carbon dioxide or dry powder extinguishers may be ineffective.
Special Firefighting For single units (packages): No special requirements needed.
For larger amounts (multiple packages/pallets) of product: Since toxic,
Procedures
corrosive or flammable vapours might be evolved from fires involving this
product and associated packaging, self contained breathing apparatus and
full protective equipment are recommended for firefighters.
If possible, contain and collect firefighting water for later disposal.
Hazardous Combustion Toxic, corrosive or flammable thermal decomposition products are
expected when the product is exposed to fire.
Products
6. ACCIDENTAL RELEASE MEASURES
Personal Precautions Wear protective clothing and equipment consistent with the degree of
hazard.
Environmental Precautions For large spills, take precautions to prevent entry into waterways, sewers, or
surface drainage systems.
Clean-up Methods Collect and place it in a suitable, properly labelled container for recovery or
disposal.
Decontamination No specific decontamination or detoxification procedures have been
identified for this product.
Procedures

7. HANDLING AND STORAGE
HANDLING
General Requirements No special control measures required for the normal handling of this
product. Normal room ventilation is expected to be adequate for routine
handling of this product.
STORAGE No storage requirements necessary for occupational hazards. Follow
product information storage instructions to maintain efficacy.


Page 2 / 4
SDS Number 127468 Approved/Revised 13-Apr-2007 Version 7
OS-CAL 500 + D TABLETS
Material



8. EXPOSURE CONTROLS/PERSONAL PROTECTION
CHOLECALCIFEROL
INGREDIENT
5
GSK Occupational
Hazard Category
GSK Occupational 0.2 mcg/m3 (8 HR TWA)
Exposure Limit
PERSONAL PROTECTIVE EQUIPMENT
Eye Protection Wear approved safety glasses with side shields if eye contact is possible.
Other Equipment or Follow all local regulations if personal protective equipment (PPE) is used
in the workplace. Wash hands and arms thoroughly after handling. An eye
Procedures
wash station should be available.

9. PHYSICAL AND CHEMICAL PROPERTIES
Appearance
White.
Colour
Tablet.
Physical Form

10. STABILITY AND REACTIVITY
Stability This product is expected to be stable.
Conditions to Avoid None for normal handling of this product.

11. TOXICOLOGICAL INFORMATION
Oral Toxicity Not expected to be toxic following ingestion.
Inhalation Toxicity No studies have been conducted.
Skin Effects Irritation might occur following direct contact.
Eye Effects Severe irritation might occur following direct contact with eyes.
Sensitisation Sensitisation (allergic skin reaction) is not expected.
Genetic Toxicity Not expected to be genotoxic under occupational exposure conditions.
Carcinogenicity No components are listed as carcinogens by GSK, IARC, NTP or US
OSHA. Not expected to produce cancer in humans under occupational
exposure conditions.
Reproductive Effects Not expected to produce adverse effects on fertility or development under
occupational exposure conditions.
Other Adverse Effects None known for occupational exposure.

12. ECOLOGICAL INFORMATION
Summary No information is available about the potential of this product to produce
adverse environmental effects. Local regulations and procedures should be
consulted prior to environmental release.

13. DISPOSAL CONSIDERATIONS
Disposal Collect for recycling or recovery if possible. The disposal method for
rejected products/returned goods must ensure that they cannot be re-sold or
Recommendations
re-used.
Regulatory Requirements Observe all local and national regulations when disposing of this product.




Page 3 / 4
SDS Number 127468 Approved/Revised 13-Apr-2007 Version 7
OS-CAL 500 + D TABLETS
Material



14. TRANSPORT INFORMATION
The SDS should accompany all shipments for reference in the event of spillage or accidental release. Only
authorised persons trained and competent in accordance with appropriate national and international
regulatory requirements may prepare dangerous goods for transport.
UN Classification and Labelling
Transportation and shipping of this product is not restricted. It has no known,
Transport Information
significant hazards requiring special packaging or labelling for air, maritime, US
or European ground transport purposes.

15. REGULATORY INFORMATION
The information included below is an overview of the major regulatory requirements. It should not be
considered to be an exhaustive summary. Local regulations should be consulted for additional requirements.
EU Classification and Labelling
Exempt from requirements of EU Dangerous Preparations directive - product regulated as a medicinal
product, cosmetic product or medical device.
US OSHA Standard (29 CFR Part 1910.1200)
Classification Exempt when packaged for sale to consumers in a retail establishment.
Other US Regulations
TSCA Status Exempt

16. OTHER INFORMATION
References GSK Hazard Determination
Date Approved/Revised 13-Apr-2007 SDS Version Number 7


SDS Sections Updated
Sections Subsections
IDENTIFICATION OF SUBSTANCE / PREPARATION AND
OF COMPANY
The information and recommendations in this safety data sheet are, to the best of our knowledge, accurate
as of the date of issue. Nothing herein shall be deemed to create any warranty, express or implied. It is the
responsibility of the user to determine the applicability of this information and the suitability of the material
or product for any particular purpose.




Page 4 / 4

Search    ENTER KEYWORD
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
miraclesealants_com---s_seal_enhance_nonvoc.asp 64742-88-7
miracote_com---GLAZETOP_XT_III_COMP_A.asp 54914-37-3 2425-79-8 623-91-6 108-65-6
miracote_com---MVERS_II_Component_B_7255_10-25-07.asp 100-51-6 109-55-7 90-72-2
mnsu_edu---uni_ver-321.asp 497-19-8 14402-88-1 12125-02-9
mobilepropane_com---msds.asp 74-98-6 115-07-1 75-08-1
modernenvironmental_net---Oxine_MSDS.asp 7758-19-2 10049-04-4
molytec_com_au---MSDS_3660.asp 24448-20-2 3006-93-7 81-07-2 112945-52-5 80-15-9 27813-02-1 39382-25-7
monsterjanitorial_com---4772004.asp 98-86-2 77-83-8 628-63-7 100-52-7 140-11-4 91-64-5 141-78-6 64742-96-7
montereyagresources_com---ConditionXtra-0805-m.asp 7783-20-2 7664-38-2
montereyagresources_com---TechMaxGran-m.asp 10-27-6 10-38-2 10034-96-5
montereychemical_com---Moncide-m.asp 2163-80-6 124-65-2 75-60-5
montgomeryschoolsmd_org---Loctite_554.asp 25852-47-5 39382-25-7 80-15-9
mopbucketandwringer_com---2745097.asp 18472-51-0 106-47-8 56-55-1 67-63-0
mopbucketandwringer_com---3382080.asp 7732-18-5 151-21-3 68891-38-3 8051-30-7 61789-40-0 102-71-6 56-81-5 77-92-9 97-59-6 9016-45-9
mouldlife_co_uk---GB-EN-RENPIM_5216_POLYOL-164006700-MSDS.asp 105-59-9
mrcgene_com---msdsbcp.asp 109-70-6
mrdc_com---Copper_Nitrate_Soln._MSDS.asp 7732-18-5 23087-46-9
msds-1620.asp 147-85-3
msds-18037.asp 50-69-1
msds-19096.asp 3211-76-5 7757-93-9
msds-gsk_com---0021300b.asp 55011-47-0 44-20-8 103-90-2 125-69-9 345-78-8
msds-gsk_com---0022500a.asp 44-20-8 103-90-2 58-08-2
msds-gsk_com---0023420b.asp 44-20-8 103-90-2 41444-62-6 58-08-2
msds-gsk_com---0029150f.asp 55011-47-0 44-20-8 103-90-2 125-69-9 345-78-8 113-92-8
msds-gsk_com---0043490c.asp 44-20-8 103-90-2 61-76-7 50-81-7
msds-gsk_com---11056509.asp 44-20-8 20830-75-5
msds-gsk_com---1105690d.asp 44-20-8 55-98-1
msds-gsk_com---1105730c.asp 44-20-8 6112-76-1
msds-gsk_com---1105790a.asp 44-20-8 154-42-7
msds-gsk_com---12346704.asp 44-20-8 126-07-8
msds-gsk_com---12729505.asp 44-20-8 20830-75-5 64-17-5
msds-gsk_com---12746807.asp 44-20-8 67-97-0 59-02-9
msds-gsk_com---12773005.asp 44-20-8 8007-45-2 97-59-6 50-23-7
msds-gsk_com---12792505.asp 44-20-8 103-90-2 93-14-1 61-76-7
msds-gsk_com---12946804.asp 44-20-8 103-90-2 61-76-7
msds-gsk_com---12973801.asp 44-20-8 103-90-2 93-14-1 61-76-7 64-17-5
MSDS_2220-VF_US_11May07.asp 50-01-1 79-14-1 56-81-5 4998-76-9
MSDS_2222-VF_US_03Jul03.asp 107-41-5 57-13-6
MSDS_2331_US_16Aug06.asp 67-63-0 56-81-5 506-59-2 111-41-1 64-19-7 79-14-1 9036-19-5
MSDS_5744_UK_04Jun03.asp 13826-83-0 14075-53-7
MSDS_7210_US_15Mar05.asp 111-76-2 126-86-3
msds_anhrefractories_com---ISO-STAR_MX_USA.asp 1344-28-1 1309-48-4 9003-35-4 7782-42-5 7440-21-3 1333-86-4 4067-16-7
msds_anhrefractories_com---NARTAR_7_USA.asp 1309-48-4 68187-58-6 10124-37-5
msds_anhrefractories_com---PLASTECH_90P_STDUSA.asp 1344-28-1 14335-33-2 1302-78-9 13530-50-2 14808-60-7
msds_anhrefractories_com---UNACAST_30-90_TI_USA.asp 1309-48-4 68187-58-6 10361-03-2
msds_anhrefractories_com---UNACAST_HPU_TI.asp 1344-28-1 68187-58-6 12042-68-1 471-34-1 546-93-0
msds_anhrefractories_com---WO-6878_BATCH_USA.asp 1309-48-4 7782-42-5 7429-90-5 9003-35-4 7440-21-3 4067-16-7
msds_carboline_com---0481a1nl_2_usansi.asp 25036-25-3 540-88-5 108-88-3 25068-38-6 392662-40-7 71-36-3 75-65-0
msds_carboline_com---0497c1nl_2_usansi.asp 108-88-3 67-63-0 392662-40-7 100-51-6 9046-10-0 694-83-7 90-72-2 108-38-3 100-41-4
msds_carboline_com---8222s1nl_2_usansi.asp 014807-96-6 111-76-2 5131-66-8 78-92-2 88-12-0

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com | Ads link:HBCCHEM.INC